TaiMed Biologics Inc. (TPEX:4147)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
87.90
-2.20 (-2.44%)
Apr 2, 2025, 1:30 PM CST

TaiMed Biologics Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
580.23251.01274.11551.62572.09
Upgrade
Short-Term Investments
1,072395.49309.93406.68629
Upgrade
Trading Asset Securities
--58.75--
Upgrade
Cash & Short-Term Investments
1,652646.5642.79958.31,201
Upgrade
Cash Growth
155.58%0.58%-32.92%-20.21%-5.57%
Upgrade
Accounts Receivable
103.02160.4998.24157.78268.92
Upgrade
Other Receivables
31.328.1625.4935.4119.69
Upgrade
Receivables
134.31188.65123.73193.19288.61
Upgrade
Inventory
1,5691,2711,3891,1771,281
Upgrade
Prepaid Expenses
6.4110.014.153.544.73
Upgrade
Other Current Assets
31.1635.635.082.592.93
Upgrade
Total Current Assets
3,3942,1512,1652,3352,778
Upgrade
Property, Plant & Equipment
857.4908.26957.741,0111,065
Upgrade
Long-Term Investments
-0.943.44232.63203
Upgrade
Other Intangible Assets
539.4625.79724.38821.33940.16
Upgrade
Other Long-Term Assets
208.79207.58210.57211.19210.59
Upgrade
Total Assets
4,9993,8944,1014,6115,196
Upgrade
Accounts Payable
0.7613.50.09122.586.16
Upgrade
Accrued Expenses
11.637.4939.3951.64361.04
Upgrade
Short-Term Debt
-200200--
Upgrade
Current Portion of Long-Term Debt
27.2426.9714.32--
Upgrade
Current Portion of Leases
2.262.182.021.951.93
Upgrade
Current Unearned Revenue
74.3291.1257.4824.3437.59
Upgrade
Other Current Liabilities
18.5619.9216.5724.5754.81
Upgrade
Total Current Liabilities
134.77361.17329.86225.08461.52
Upgrade
Long-Term Debt
468.03495.04521.68536536
Upgrade
Long-Term Leases
25.126.6728.1229.3831.32
Upgrade
Long-Term Unearned Revenue
347.53444.04505.6877.9750.74
Upgrade
Other Long-Term Liabilities
0.920.920.920.870.86
Upgrade
Total Liabilities
976.341,3281,3861,6691,780
Upgrade
Common Stock
2,7312,5302,5262,5232,522
Upgrade
Additional Paid-In Capital
2,452986.67945.45925.144,832
Upgrade
Retained Earnings
-1,136-934.56-740.22-470.93-3,921
Upgrade
Comprehensive Income & Other
-23.89-16.13-15.83-35.97-17.6
Upgrade
Shareholders' Equity
4,0232,5662,7152,9423,416
Upgrade
Total Liabilities & Equity
4,9993,8944,1014,6115,196
Upgrade
Total Debt
522.63750.86766.14567.32569.25
Upgrade
Net Cash (Debt)
1,130-104.35-123.35390.98631.84
Upgrade
Net Cash Growth
----38.12%-48.96%
Upgrade
Net Cash Per Share
4.21-0.41-0.491.552.51
Upgrade
Filing Date Shares Outstanding
273.08253.01252.55252.33252.22
Upgrade
Total Common Shares Outstanding
273.08253.01252.55252.33252.22
Upgrade
Working Capital
3,2591,7901,8352,1102,316
Upgrade
Book Value Per Share
14.7310.1410.7511.6613.54
Upgrade
Tangible Book Value
3,4841,9401,9912,1202,476
Upgrade
Tangible Book Value Per Share
12.767.677.888.409.82
Upgrade
Land
194.61194.61194.61194.61194.61
Upgrade
Buildings
495.41493.95493.54493.12492.72
Upgrade
Machinery
457.35455.56450.03446.9443.66
Upgrade
Leasehold Improvements
4.644.644.644.644.64
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.